Log in

Blackmores Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: A$75.90
52-Week Range N/A
Volume75,759 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield2.95%
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, and Asia. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of heart and circulation, infant nutrition, kids and men's health, nails, hair and skin, pet health, pregnancy and preconception, stress relief, weight management, and women's health, as well as fish and nutritional oils, probiotics, and multivitamins. Further, it provides naturopathic advisory services. The company offers its products through pharmacies, mass merchandisers, groceries, health food stores, practitioners, vets, and wholesalers, as well as through online channel. Blackmores Limited was founded in 1930 and is headquartered in Sydney, Australia.
Read More
Blackmores logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars

Industry, Sector and Symbol

Industry Personal Products



Sales & Book Value

Annual Sales$571.89 million
Book ValueA$16.35 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive BKL News and Ratings via Email

Sign-up to receive the latest news and ratings for BKL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Blackmores (ASX:BKL) Frequently Asked Questions

How were Blackmores' earnings last quarter?

Blackmores Limited (ASX:BKL) announced its quarterly earnings results on Tuesday, February, 19th. The company reported $1.99 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $2.18 by $0.19.
View Blackmores' earnings history

Who are some of Blackmores' key competitors?

What other stocks do shareholders of Blackmores own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blackmores investors own include Altium (ALU), Bonavista Energy (BNP), Champion Iron (CIA), CSL (CSL), Fisher & Paykel Healthcare (FPH), Oncosil Medical (OSL), Pinnacle West Capital (PNW), Select Harvests (SHV), Smartgroup (SIQ) and TPG Telecom (TPM).

Who are Blackmores' key executives?

Blackmores' management team includes the following people:
  • Mr. Richard Henfrey M.D., MD, CEO & Director
  • Mr. Marcus C. Blackmore AM ND, MAICD, D Univ, Interim CEO & Exec. Director (Age 74)
  • Mr. Aaron Boyd Canning BCom(Hons), CA, FCCA, GAICD, CFO & Joint Company Sec.
  • Mr. Peter Osborne, Managing Director of Asia
  • Mr. David Fenlon, Managing Director of Australia & New Zealand

What is Blackmores' stock symbol?

Blackmores trades on the ASX under the ticker symbol "BKL."

How big of a company is Blackmores?

Blackmores has a market capitalization of $0.00 and generates $571.89 million in revenue each year. Blackmores employs 1,400 workers across the globe.

What is Blackmores' official website?

The official website for Blackmores is www.blackmores.com.au.

How can I contact Blackmores?

Blackmores' mailing address is 20 Jubilee Ave, SYDNEY, NSW 2102, Australia. The company can be reached via phone at +61-2-99105000.

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.